Independent Financial Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,738
Closed -$9.48K 684
2020
Q4
$9.48K Sell
13,738
-1,737
-11% -$3.7K ﹤0.01% 566
2020
Q3
$34.8K Buy
15,475
+232
+2% +$663 0.01% 505
2020
Q2
$54.6K Buy
15,243
+1,666
+12% +$6.01K 0.01% 471
2020
Q1
$51.6K Buy
+13,577
New +$44.7K 0.02% 403

Other funds holding BMY.RT

Independent Financial Group's BMY.RT Position: Q1 2021 in Review

Independent Financial Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,738 shares — an estimated $9.48K sold.

Independent Financial Group first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $54.6K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Independent Financial Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Independent Financial Group sold 13,738 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9.48K.
  • Independent Financial Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Independent Financial Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $54.6K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Independent Financial Group's 13F filing for Q1 2021, filed 15 Jun 2026.